000			02120 a2200541 4500
005			20250513195113.0
264		0	_c19991208
008			199912s 0 0 eng d
022			_a0953-816X
024	7		_a10.1046/j.1460-9568.1999.00761.x _2doi
040			_aNLM _beng _cNLM
100	1		_aHall, A C
245	0	0	_aRole of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y. _h[electronic resource]
260			_bThe European journal of neuroscience _cOct 1999
300			_a3424-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a2-Amino-5-phosphonovalerate _xpharmacology
650	0	4	_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnisomycin _xpharmacology
650	0	4	_aCircadian Rhythm _xdrug effects
650	0	4	_aCricetinae
650	0	4	_aCycloheximide _xpharmacology
650	0	4	_aElectric Conductivity
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aGlutamic Acid _xphysiology
650	0	4	_aIonophores _xpharmacology
650	0	4	_aMale
650	0	4	_aMembrane Potentials _xdrug effects
650	0	4	_aMesocricetus
650	0	4	_aNerve Tissue Proteins _xbiosynthesis
650	0	4	_aNeurons _xchemistry
650	0	4	_aNeuropeptide Y _xpharmacology
650	0	4	_aOrgan Culture Techniques
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aPotassium _xmetabolism
650	0	4	_aPotassium Channels _xphysiology
650	0	4	_aProtein Synthesis Inhibitors _xpharmacology
650	0	4	_aSodium _xmetabolism
650	0	4	_aSodium Channels _xphysiology
650	0	4	_aSuprachiasmatic Nucleus _xcytology
650	0	4	_aTetraethylammonium _xpharmacology
650	0	4	_aValinomycin _xpharmacology
700	1		_aEarle-Cruikshanks, G
700	1		_aHarrington, M E
773	0		_tThe European journal of neuroscience _gvol. 11 _gno. 10 _gp. 3424-32
856	4	0	_uhttps://doi.org/10.1046/j.1460-9568.1999.00761.x _zAvailable from publisher's website
999			_c10520642 _d10520642